22nd Century Group, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison

Sell

25

XXII
22nd Century Group, Inc.

Last Price:

$0.83

Seasonality Move:

1310.65%

Buy

57

APLS
Apellis Pharmaceuticals, Inc.

Last Price:

$25.18

Seasonality Move:

7.92%

Sell

25

22nd Century Group, Inc. (XXII) is a Sell

Is 22nd Century Group, Inc. a Buy, Sell or Hold?

The current 22nd Century Group, Inc. [XXII] share price is $0.83. The Score for XXII is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
XXII is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

57

Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.17. The Score for APLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XXII Stock Price Chart

What is 22nd Century Group, Inc.'s stock price today?

The 22nd Century Group, Inc. share price today is $0.83

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

The Apellis Pharmaceuticals, Inc. share price today is $25.17

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

XXII Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.07	Sell
Relative Strength Index (14 RSI):	34.95	Sell
Chaikin Money Flow:	-66367	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.88 - 1.08)	Sell
Bollinger Bands (100):	(1.06 - 1.96)	Sell

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.82	Buy
Relative Strength Index (14 RSI):	60.62	Buy
Chaikin Money Flow:	1135541	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(21.49 - 25.29)	Buy
Bollinger Bands (100):	(21.37 - 27.13)	Buy

XXII Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.93	Sell
20-day SMA:	1.01	Sell
50-day SMA:	1.15	Sell
200-day SMA:	9.89	Sell
8-day EMA:	0.91	Sell
20-day EMA:	0.98	Sell
50-day EMA:	1.31	Sell
200-day EMA:	1747.85	Sell

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	24.98	Buy
20-day SMA:	24.05	Buy
50-day SMA:	23.18	Buy
200-day SMA:	21.91	Buy
8-day EMA:	24.93	Buy
20-day EMA:	24.14	Buy
50-day EMA:	23.47	Buy
200-day EMA:	24.31	Buy

22nd Century Group, Inc. Earnings Growth & XXII Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.44 per share.

22nd Century Group, Inc. Technical Analysis

	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 24	Dec 26	Dec 29
	Dec
	12	15	16	17	18	19	22	24	26	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals, Inc. Technical Analysis

	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19	Dec 22	Dec 23	Dec 24	Dec 26	Dec 29
	Dec
	15	16	17	18	19	22	23	24	26	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):